Will Congress revert tax law to allow for full expensing of US-based R&D in 2025?
6
Ṁ1kṀ5.6kresolved Oct 13
Resolved
YES1H
6H
1D
1W
1M
ALL
Before 2022, businesses could deduct their R&D expenses immediately (full expensing); after 2022, companies amortize R&D expenses over 5 years in the US and 15 years if foreign.
This question is just about US-based R&D, which could be a component of a broader tax package Congress is likely to address this year. Such a component has meaningful implications for AI/software/tech, etc..
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ1,455 |
Sort by:
@mods this did indeed happen as part of the one big beautiful bill act (https://www.grantthornton.com/insights/alerts/tax/2025/insights/full-expensing-of-domestic-research).
Creator has deleted their account but this should clearly resolve as yes given the market description. Thanks!
People are also trading
Related questions
Will the Responsible Innovation and Safe Expertise (RISE) Act of 2025 become law in the United States before 1 Jan 2027?
22% chance
By 31 December 2026, will the Congress pass a DBCFT (Destination Based Cash Flow Tax)?
20% chance
Will Section 45X Advanced Manufacturing Production Tax Credit be cut in at least half by 2027?
50% chance
Will the "Stepped Up Basis" rule be eliminated in the US federal tax code before 2035?
31% chance
Will Congress ameliorate the ACA subsidy cliff for the 2026 tax year?
31% chance
Will there be any tax on unrealized capital gains in the USA before eoy2028?
12% chance
Will the US enact a federal compute tax before 2030?
21% chance
Will the US continue to use a Standard Deduction in determining income tax by end of 2030?
87% chance